The All Ordinaries may be charging higher in 2019, but not all shares on the index are flying high.
Three shares which have crashed lower this year are listed below. Is this a buying opportunity for investors?
The AusCann Group Holdings Ltd (ASX: AC8) share price has fallen 29% in 2019. The medicinal cannabis company's slow progress and lack of meaningful revenue generation appears to have disappointed investors. Especially given the progress that some of its rivals have made this year such as Althea Group Holdings Ltd (ASX: AGH). After being a front runner for some time, I think AusCann has lost valuable ground and Althea is now the likeliest winner in the Australian medicinal cannabis industry.
The Blackmores Limited (ASX: BKL) share price is down over 32% since the start of the year. Investors have sold off the health supplements company's shares this year due to its disappointing performance in FY 2019. This has been driven by the softening of demand for its products in the key China market. And although its shares now look reasonable value, I think it would be prudent to wait for its full year results release later this month and its guidance for FY 2020.
The Galaxy Resources Limited (ASX: GXY) share price is down a massive 40% in 2019. Galaxy and the rest of the lithium miners have come under pressure this year after a collapse in prices of the battery making ingredient. This has been caused by increasing supply and weakening demand from Chinese battery makers. But there are signs that the worst could be over now. Last week lithium giant Albemarle announced a stronger than expected quarterly update and upgraded its full year profit guidance. It also suggested that lithium prices could strengthen in the near term. If this occurs and is sustained then Galaxy could prove to be great value, though it may be best waiting for proof of this before considering an investment.
